Alexis Borisy, the founder of multiple biotech companies and self-dubbed “man of many hats,” may have to reduce two of his many duties. The Blueprint Medicines co-founder lost a majority vote for his ...
San Diego-based Blueprint Equity surpasses $600M in AUM as it continues backing capital-efficient, high-growth businesses overlooked by traditional venture capital. The Fund will make $5 – 15 million ...
Blueprint's Albers hands CEO baton to deal mastermind Haviland after steering 2 cancer drug launches
When Jeff Albers joined Blueprint Medicines in 2014, the private company was a clinical-stage biotech. Now, the helmsman is handing down the reins after steering the firm through an IPO and two drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results